Guangzhen Cai
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62-Keap1-Nrf2 pathway.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: January 06, 2026
Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma.
Journal: Annals of surgical oncology
Published: August 26, 2025
Vessels encapsulating tumor clusters is associated with impaired efficacy of adjuvant immunotherapy in resected hepatocellular carcinoma.
Journal: Journal of advanced research
Published: June 05, 2025
Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma.
Journal: Cancer communications (London, England)
Published: September 24, 2024
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy.
Journal: Cancer letters
Published: June 27, 2023
Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.
Journal: Cell death and differentiation
Published: July 07, 2021
Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis.
Journal: Journal of Cancer
Published: July 17, 2020
A small nucleolar RNA, SNORD126, promotes adipogenesis in cells and rats by activating the PI3K-AKT pathway.
Journal: Journal of cellular physiology
Published: March 10, 2020
Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma.
Journal: Journal of cellular physiology
Published: February 21, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026